Electroporatic delivery of TGF-β1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice: Commentary

Journal of Investigative Dermatology

Volumn 123, Issue 4, 2004, Pages 11-

  Mulder, Gerit ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Phase I Clinical Trials in Progress   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; DECUBITUS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; ELECTROPORATION; ELECTROSTIMULATION; ELECTROSTIMULATION THERAPY; FOOT ULCER; GENE THERAPY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NOTE; PRIORITY JOURNAL; SKIN ULCER; WOUND HEALING;

EID: 4644255388     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23301.x     Document Type: Note

References (4)

1. Frykberg RG, Armstrong DG: The Diabetic Foot 2001: A summary of the Proceedings of the American Diabetes Association's 61st Scientific Symposium. J Am Podiatr Assoc 92:2-6, 2002
2. Kloth LC: Electrical stimulation in tissue repair. In: McCullough JM, Kloth LC, Feedar JA (eds). Wound Healing: Alternatives in Management. Philadelphia: FA Davis Company, 1995; p 275-314
3. National Diabetes Data Group Diabetes in America. Bethesda, MD: Department of Health and Human Services, 1995; p 85
4. Smiell JM, Wieman TJ, Steed DL, et al: Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-bb) in patients with nonhealing, lower extremity diabetic ulcers: A combined analysis of four randomized studies. Wound Repair Regeneration 7:335-346, 1999